Invention Grant
- Patent Title: Radioactive mixture and manufacturing method thereof
- Patent Title (中): 放射性混合物及其制造方法
-
Application No.: US12354815Application Date: 2009-01-16
-
Publication No.: US08048405B2Publication Date: 2011-11-01
- Inventor: Tsai-Yueh Luo , I-Chung Tang , Show-Wen Liu , Yu-Lung Wu , Cheng-Hsien Lin , Cheng-Fang Hsu , Kwei-Luen Hsu , Chang-Mau Sheng , Ching-Jun Liou , Te-Sheng Liang
- Applicant: Tsai-Yueh Luo , I-Chung Tang , Show-Wen Liu , Yu-Lung Wu , Cheng-Hsien Lin , Cheng-Fang Hsu , Kwei-Luen Hsu , Chang-Mau Sheng , Ching-Jun Liou , Te-Sheng Liang
- Applicant Address: TW Taoyuan County
- Assignee: Atomic Energy Council-Institute of Nuclear Energy Research
- Current Assignee: Atomic Energy Council-Institute of Nuclear Energy Research
- Current Assignee Address: TW Taoyuan County
- Agency: Sinorica, LLC
- Agent Ming Chow
- Main IPC: A61K49/00
- IPC: A61K49/00

Abstract:
A radioactive mixture and a manufacturing method thereof are disclosed. The radioactive mixture (188Re-MN/Lipiodol mixture) is formed by chelating reaction of MN series compounds that are amine-amide-disulfide amine quadric-dentate chelate ligands with TcO4−/or ReO4−, and then dissolved in Lipiodol. Moreover, the 99mTc/or 188Re of the TcO4−/or ReO4− avoids bone marrow injuries caused by free 90Y. By the feature of the Lipiodol that stays in liver tumors for a long period, the radioactive mixture is applied to treat liver cancers by injection so that injuries caused by surgical operations can be prevented. 188Re-MN/Lipiodol is used for liver cancer, breast cancer or other solid tumors treatment. Re-188 MN or Re-188 MN/Lipiodol can be mixed with anticancer drugs, hydrogel, liposome, micelle or other nano-particles to form the multifunctional therapeutic modality.
Public/Granted literature
- US20100183508A1 RADIOACTIVE MIXTURE AND MANUFACTURING METHOD THEREOF Public/Granted day:2010-07-22
Information query